Pharma Marketing Network

APRIL 16, 2025

Behavioral and Intent Data Data from search behavior, content consumption, webinar participation, and online forum interactions (including platforms like Pharma Marketing Network ) reveal where an HCP or patient is in their decision journey. This real-time insight helps tailor messaging dynamically.

HIPAA 59

HIPAA Documentation Pharmaceutical Companies Pharmaceutical Companies 59

Putting Patients First Blog

JULY 2, 2024

Clarify What Information is Sought from Speakers Report on Data Utilization Host Educational Webinars Before Listening Sessions Market as Stakeholder Listening Sessions if They Have Broader Representation Improve the Structure of the Listening Sessions. Finally, we encourage CMS to consider a longer time horizon for the submission of data.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling HIPAA 52

FDA Law Blog: Biosimilars

MAY 26, 2025

Hull & JP Ellison At our webinar earlier this month, we talked about Administration priorities as they relate to the FDC Act and noted that we expect much to remain the same with respect to enforcement. The gray box at the top of the document at this link shows the change in position. By Andrew J.

Labelling 59

Labelling HIPAA Documentation Immunity 59